All News

The breast cancer drug palbociclib may be able to treat myelofibrosis either alone or in combination with ruxolitinib.

Most patients said they had received instruction on how to use their inhalers from a pharmacist or physician, but only 21% said they had received instruction from both.

Catlin Dennis, MPH, explains the importance of securing internet and technology access among vulnerable youth with diabetes.

The Biden administration announces the largest permanent increase in SNAP benefits history; a potential decision timeline on whether to offer COVID-19 booster shots to Americans may be on the horizon; children hospitalized with COVID-19 reaches a new record high.

The pandemic has shown a spotlight on how critically important respiratory care is to Americans who struggle to breathe on their own. Yet, Medicare policy must be updated to ensure that access to lifesaving equipment will never be disrupted.

A roundup of the latest news in sleep research reported across MJH Life Sciences™.

A recent study aimed to understand whether psoriasis and psoriatic arthritis are independent risk factors for coronary calcification and coronary artery disease. It found both correlate with higher rates of calcification, but only psoriasis was linked with severe calcification and disease.

Early responders to the World Trade Center after the 9/11 attacks are associated with a higher likelihood of liver disease, according to a long-term follow-up of responders.

New strategies are currently being investigated to find out how to avoid resistance to immune checkpoint inhibitors and BRAF/MEK inhibitors.

Updated evidence provides new insight into safety, efficacy, and challenges of deprescribing.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

The combination delayed disease progression for a year and a half, suggesting the treatments may be a viable option for patients not eligible for allogeneic stem cell transplantation.

Patients with chronic cough reported autonomic symptoms with substantially increased frequency and severity when compared with a healthy control population.

Use of a smartphone-based application was found to improve medication adherence and some clinical outcomes in patients managing multiple comorbidities using polypharmacy, researchers concluded.

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, speaks on the impact of screen usage for eyes and trends in eye symptom burden reported amid the pandemic.

Risk of isolated central nervous system (CNS) involvement was found to be significantly lower in patients with diffuse large B-cell lymphoma who received high-dose methotrexate vs RCHOP chemotherapy, although risk of concomitant CNS-systemic relapse rates were similar between both groups.

Findings of a randomized controlled trial revealed no differences among HIV diagnosis rates between targeted screening practices when compared with nontargeted practices.

More than three-quarters of patients with rheumatic diseases quarantined and kept social distance during the pandemic, according to a new global survey.

Patients with nephrotic syndrome were far more likely than healthy controls to suffer end-stage kidney disease, particularly if they had focal segmental glomerulosclerosis or membranous nephropathy.

Recent research showed that patients with Medicaid are more likely than commercially insured patients to have worsened end-of-life experience and that Black patients with breast cancer fare worse than other ethnic groups when it comes COVID-19 outcomes.

Nearly 9 in 10 children given intravenous (IV) magnesium for refractory asthma ended up being admitted to the hospital, but new research suggests that may be partly due to a lack of clarity about the therapy’s safety profile.

Mortality risk stratification can identify patients with COVID-19 who are at higher risk of mortality, discharge to skilled nursing facility, and readmission, and may benefit from focused intervention strategies.

President Joe Biden pushes for measures aimed at lowering drug prices; the Supreme Court allows a vaccine mandate imposed by Indiana University to stand; heat advisories issued for almost 200 million Americans.

The meeting comes a day after the FDA approved a third dose of a COVID-19 vaccine from Pfizer-BioNTech and Moderna in people who have received organ transplants or have other conditions that have damaged their immune systems.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Jazz Pharmaceuticals’ Xywav oral solution is the first treatment to be approved for adults with idiopathic hypersomnia.

Many intrinsic and extrinsic factors hinder primary health care professionals from identifying a patient as having occupational asthma.

Results of the phase 3 REST-ON study exhibited significant improvement in patients with narcolepsy treated with once-nightly sodium oxybate, FT218, versus placebo.